The Innovation Blueprint

Episode 44 Heart Failure Treatment Breakthroughs: A Conversation with Ayla Annac

33 min · 5. heinä 2026
jakson Episode 44
Heart Failure Treatment Breakthroughs: A Conversation with Ayla Annac kansikuva

Kuvaus

Heart failure is still one of the world’s leading causes of death, yet investment and innovation continue to lag behind cancer research. Ayla Annac explains why large-scale cardiac trials keep failing, how AI could radically improve patient targeting, and why the future of precision medicine depends on collaboration between pharma, hospitals, software teams, and regulators. From clinical trial design to patient data ethics, the conversation explores what it will take to finally modernize cardiac drug development.

Kommentit

0

Ole ensimmäinen kommentoija

Rekisteröidy nyt ja liity The Innovation Blueprint-yhteisöön!

Aloita maksutta

14 vrk ilmainen kokeilu

Kokeilun jälkeen 7,99 € / kuukausi. · Peru milloin tahansa.

  • Podimon podcastit
  • 20 kuunteluaikaa / kuukausi
  • Lataa offline-käyttöön

Kaikki jaksot

44 jaksot